NCT07210775View on ClinicalTrials.gov

Topical Imiquimod Treatment of Oral Dysplasia

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Oral DysplasiaLeukoplakia OralLeukoplakia
Interventions
DRUG

Imiquimod (topical use)

Participants will be prescribed imiquimod 5% cream, with instructions to apply the cream with soft tray or gauze daily for one hour, five days a week (Monday to Friday). 6 week as one course and additional course may be added based on participant's conditions and consent. 2 follow up biopsies are scheduled 6 months and 12 months after the start of the treatment course.

Trial Locations (1)

90089

RECRUITING

OralCare PreCancer and Pain Clinic, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT07210775 - Topical Imiquimod Treatment of Oral Dysplasia | Biotech Hunter | Biotech Hunter